Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4800480
Max Phase: Preclinical
Molecular Formula: C43H65F2N9O7
Molecular Weight: 858.04
Molecule Type: Unknown
Associated Items:
ID: ALA4800480
Max Phase: Preclinical
Molecular Formula: C43H65F2N9O7
Molecular Weight: 858.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1
Standard InChI: InChI=1S/C43H65F2N9O7/c1-28(2)41-52-51-29(3)54(41)35-22-33-12-13-34(23-35)53(33)21-16-36(50-42(59)31-14-17-43(44,45)18-15-31)30-8-10-32(11-9-30)49-40(58)27-61-26-39(57)48-20-7-5-6-19-47-38(56)25-60-24-37(55)46-4/h8-11,28,31,33-36H,5-7,12-27H2,1-4H3,(H,46,55)(H,47,56)(H,48,57)(H,49,58)(H,50,59)/t33-,34+,35+,36-/m0/s1
Standard InChI Key: ULNSLDNOQCRUOZ-NZKHRDNMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 858.04 | Molecular Weight (Monoisotopic): 857.4975 | AlogP: 4.07 | #Rotatable Bonds: 23 |
Polar Surface Area: 197.91 | Molecular Species: BASE | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.92 | CX Basic pKa: 9.29 | CX LogP: 0.35 | CX LogD: -1.54 |
Aromatic Rings: 2 | Heavy Atoms: 61 | QED Weighted: 0.10 | Np Likeness Score: -0.97 |
1. Arnatt CK,Falls BA,Yuan Y,Raborg TJ,Masvekar RR,El-Hage N,Selley DE,Nicola AV,Knapp PE,Hauser KF,Zhang Y. (2016) Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization., 24 (22.0): [PMID:27720326] [10.1016/j.bmc.2016.09.059] |
Source(1):